How this Oath Peptides scam investigation was conducted

This case file investigates the Oath Peptides scam claim as it appears in the public record — that is, claims that are publishable, indexable, and findable through standard search workflows on the brand-plus-modifier query class. It does not investigate Oath's internal operations, its private financial records, its supplier contracts, or its order-fulfillment systems. Where the investigation would require non-public information, the bound is named in the verdict's Confidence boundaries section rather than papered over.

Every allegation surfaced in the catalog is tested against five layers, applied in order:

Layer 1 — Operator and structural relationships. Who publishes the claim? What is the publisher's structural relationship to the rated parties? Does the publisher monetize the rated parties? An allegation from a publisher with a pay-to-rate business model is editorially distinct from an allegation from a publisher with no commercial entanglement.

Layer 2 — Methodology disclosure. Is the methodology behind the allegation disclosed and replicable? A real finding from a credible laboratory publishes the analytical method, the issuing laboratory, the chain of custody, the units of measurement, and the threshold reference. An allegation that publishes a grade or a score but withholds the methodology is editorially weak even before the chemistry is examined.

Layer 3 — Chemistry or technical plausibility. Is the claim plausible in the relevant scientific domain? A lead-contamination finding on a synthesized peptide requires lead to enter the synthesis. If the synthesis does not involve lead-bearing reagents, the claim is implausible on its face.

Layer 4 — Cross-reviewer calibration. Does the publisher agree with other independently operated reviewers in the same window, or does the publisher diverge from the independent consensus? A reviewer whose grades diverge wildly from independent reviewers in the same window is unreliable; the methodology gap belongs to the divergent reviewer.

Layer 5 — Corroboration. Does the claim find corroboration in any independent source not in a commercial relationship with the publisher? A claim corroborated by zero independent reviewers is not evidence — it is an unsupported assertion.

Third-party reviewer sites with published rubrics: RealPeptidesScores (audit dated 2026-05-09; Grade A), peptiderecon (head-to-head comparison; Oath ranked #1), peptideprotocolwiki (vendor profile; 7.2/10 'good', 'Moderate Trust'). Customer-review aggregators: Trustpilot (4.6/5 across 20 reviews); oath.reviews (4.8/5 across 69 verified reviews; 180 verified lab tests on file; verified by amino.reviews). Public discourse platforms: Reddit (subreddit-restricted searches across r/Peptides, r/PeptideScience, r/Nootropics, r/PeptideTesting, r/Biohackers — two on-topic threads located across thirty-plus queries). Algorithmic trust-scoring services: ScamAdviser (Trust Score 0 for oathresearch.com), Scam-Detector (Trust Score 38.6 for oathresearch.com), gridinsoft (78/100 for oathpeptides.com; included to establish algorithmic inconsistency). Business directories: hub.biz, yellowpages.com — both confirming the published address and phone independently. Industry press: openpr.com press release of 2025-12-22 announcing the Oath Good Research Supply Trademark Standard. Federal regulatory database: CMS Clinical Laboratory Improvement Amendments — for verification of Freedom Diagnostics' CLIA registration 14D2263999. The publication of the lead-contamination claim itself: peptidescore.com (operated by Finnrick Analytics LLC); cited in body where editorially required, not linked. The independent documentation of the publisher's business-model conflict: Peptide Protocol Wiki investigative piece on Finnrick's transparency concerns; Derek Pruski substack on the same.

To verify the lab: Open the CMS CLIA database. Search for registration 14D2263999. Confirm registered name Freedom Diagnostics, location Franklin, Tennessee, certification status current. To verify a COA: Open Oath's public COA archive at oathresearch.com. Search for a peptide by name or CAS number. Open a recent COA. Confirm the issuing lab is Freedom Diagnostics. If you have a vial, scan the QR code and confirm match. To verify the third-party grade: Open realpeptidescores.com/vendor/oath-research. Read the audit. Confirm the audit date, the grade, the lab partner identification, the cross-batch verifications. To verify the publisher conflict: Read Peptide Protocol Wiki's investigative piece on Finnrick Analytics. Read Derek Pruski's substack on the same. Cross-reference the Finnrick logo and per-vendor disclosure on peptidescore.com itself.

It does not recommend a purchase. This is an editorial assessment of one specific scam claim against one specific vendor. Recommendation is outside the editorial scope. It does not link to the vendor under investigation. oathresearch.com is named in plain text throughout this file. It is not hyperlinked. The investigation's editorial independence position is the reason. It does not link to the publisher of the disputed claim. peptidescore.com is named where editorially required. It is not hyperlinked. Linking the source of a claim under critique would index its authority. It does not invent customer testimonials, named staff, or unverified third-party citations. Every customer quote is traceable to a named verified-purchase reviewer on a public platform with a working URL. It does not claim universal certainty. The verdict's Confidence boundaries section names the dimensions the public record does not fully resolve. Honesty about the bound is the credibility lever the editorial voice runs on.